RCMI Public Lecture - Long COVID in Canada: CANCOV, RECLAIM and Long COVID Web (只有英文版本)
研究院/研究中心讲座
-
日期
2024年1月12日
-
主办单位
Research Centre for Chinese Medicine Innovation
-
时间
10:00 - 11:00
-
地点
M1603, PolyU & Online via Zoom
讲者
Prof. Angela M. CHEUNG
摘要
Abstract
The COVID-19 pandemic has caused major morbidity and mortality internationally. Over the past 3-4 years, we have learnt a great deal about the SARS-CoV-2 virus and how it can affect various systems in our body. In this talk, Prof. Cheung will discuss learnings from 1) CANCOV, a Canadian longitudinal cohort study of COVID-19 across the spectrum of illness severity, 2) RECLAIM, a Canadian adaptive platform trial on interventions for the treatment of post-COVID condition, and 3) Long COVID Web, a national research platform for post-COVID condition in Canada. She will also discuss the current understanding of post-COVID condition (i.e. symptoms lingering long after the acute infection) and how COVID-19 changed the practice of medicine in Canada.
Biography
Prof. Angela M. Cheung is a Professor of Medicine, KY and Betty Ho Chair in Integrative Medicine at University of Toronto (UT) and Senior Physician Scientist at University Health Network (UHN). She has held many awards including the Canadian Institutes of Health Research Mid-Career and Senior Investigator awards, Canadian Society of Internal Medicine David Sackett Senior Investigator award, Ontario Premier Research Award, UT Eudenie Stuart Mentorship award, UT Eaton Scholar Award and a Tier 1 Canada Research Chair for her clinical research. She is the PI of CANCOV (a national longitudinal cohort study of COVID-19), RECLAIM (the adaptive platform trial for interventions for long COVID), and Long COVID Web (a national research network for Post-COVID Condition). She has served as an advisor for Ontario Science Table, Public Health Agency of Canada, Canadian Immunity Task Force, Canadian Institutes of Health Research, Canadian Agency for Drugs and Technologies in Health and the Chief Science Advisor’s Task Force on Post COVID Condition. She obtained her M.D. (1988) from Johns Hopkins University School of Medicine, and her PhD (1997) from Harvard University. She is an Internal Medicine specialist and a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for over 30 years.
The COVID-19 pandemic has caused major morbidity and mortality internationally. Over the past 3-4 years, we have learnt a great deal about the SARS-CoV-2 virus and how it can affect various systems in our body. In this talk, Prof. Cheung will discuss learnings from 1) CANCOV, a Canadian longitudinal cohort study of COVID-19 across the spectrum of illness severity, 2) RECLAIM, a Canadian adaptive platform trial on interventions for the treatment of post-COVID condition, and 3) Long COVID Web, a national research platform for post-COVID condition in Canada. She will also discuss the current understanding of post-COVID condition (i.e. symptoms lingering long after the acute infection) and how COVID-19 changed the practice of medicine in Canada.
Biography
Prof. Angela M. Cheung is a Professor of Medicine, KY and Betty Ho Chair in Integrative Medicine at University of Toronto (UT) and Senior Physician Scientist at University Health Network (UHN). She has held many awards including the Canadian Institutes of Health Research Mid-Career and Senior Investigator awards, Canadian Society of Internal Medicine David Sackett Senior Investigator award, Ontario Premier Research Award, UT Eudenie Stuart Mentorship award, UT Eaton Scholar Award and a Tier 1 Canada Research Chair for her clinical research. She is the PI of CANCOV (a national longitudinal cohort study of COVID-19), RECLAIM (the adaptive platform trial for interventions for long COVID), and Long COVID Web (a national research network for Post-COVID Condition). She has served as an advisor for Ontario Science Table, Public Health Agency of Canada, Canadian Immunity Task Force, Canadian Institutes of Health Research, Canadian Agency for Drugs and Technologies in Health and the Chief Science Advisor’s Task Force on Post COVID Condition. She obtained her M.D. (1988) from Johns Hopkins University School of Medicine, and her PhD (1997) from Harvard University. She is an Internal Medicine specialist and a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for over 30 years.
